A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran

Introduction: Multidrug-resistant (MDR) bacteria like Proteus species have led to more prolonged hospitalizations, fewer care choices, higher treatment costs, and even death. The present study aims to evaluate the prevalence of MDR Proteus species in clinical samples and to suggest the best therape...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahnaz Shafaei Fallah, Hadi Razavi Nikoo, Aylar Jamali, Alireza Mohebbi, Ezzat Allah Ghaemi
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2024-12-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/17637
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849313608035467264
author Mahnaz Shafaei Fallah
Hadi Razavi Nikoo
Aylar Jamali
Alireza Mohebbi
Ezzat Allah Ghaemi
author_facet Mahnaz Shafaei Fallah
Hadi Razavi Nikoo
Aylar Jamali
Alireza Mohebbi
Ezzat Allah Ghaemi
author_sort Mahnaz Shafaei Fallah
collection DOAJ
description Introduction: Multidrug-resistant (MDR) bacteria like Proteus species have led to more prolonged hospitalizations, fewer care choices, higher treatment costs, and even death. The present study aims to evaluate the prevalence of MDR Proteus species in clinical samples and to suggest the best therapeutic options for the MDR Proteus species. Methodology: Clinical samples were collected randomly from five hospitals in Golestan Province, Iran, from February 2017 to July 2019. Disk diffusion on Mueller–Hinton agar plates were used to perform antibiotic susceptibility testing (ASTs). By using a double-disc synergy test (DDST), isolates resistant to one of the third-generation cephalosporins were examined for phenotypic extended-spectrum β-lactamase (ESBL) development. A combined double disk synergy test (CDDST) was used to identify MBL-producing isolates. Results: 61 Proteus isolates, including P. Mirabilis 44/61 (77.04%), P. vulgaris 7/61 (11.47%), P. hauseri 5/61 (8.19%), and P. penneri 2/61 (3.27%) were collected. Most of the isolates were obtained from urine samples. P. hauseri isolates were more frequent in females. Resistance to tetracycline and nitrofurantoin antibiotics was observed in most Proteus isolates. P. penneri isolates were all resistant to antibiotics. ESBL production was observed in five ceftazidime-resistant isolates (p < 0.05). Conclusions: Cefepime and imipenem were found to have the lowest occurrence of antibiotic resistance among Proteus species, confirming that cefepime and imipenem can be used to treat Proteus infections.
format Article
id doaj-art-e74c3e6bcdc0487d856cb817b193a57e
institution Kabale University
issn 1972-2680
language English
publishDate 2024-12-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-e74c3e6bcdc0487d856cb817b193a57e2025-08-20T03:52:42ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802024-12-01181210.3855/jidc.17637A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern IranMahnaz Shafaei Fallah0Hadi Razavi Nikoo1Aylar Jamali2Alireza Mohebbi3Ezzat Allah Ghaemi4Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, IranDepartment of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, IranDepartment of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, IranDepartment of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, IranLaboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran Introduction: Multidrug-resistant (MDR) bacteria like Proteus species have led to more prolonged hospitalizations, fewer care choices, higher treatment costs, and even death. The present study aims to evaluate the prevalence of MDR Proteus species in clinical samples and to suggest the best therapeutic options for the MDR Proteus species. Methodology: Clinical samples were collected randomly from five hospitals in Golestan Province, Iran, from February 2017 to July 2019. Disk diffusion on Mueller–Hinton agar plates were used to perform antibiotic susceptibility testing (ASTs). By using a double-disc synergy test (DDST), isolates resistant to one of the third-generation cephalosporins were examined for phenotypic extended-spectrum β-lactamase (ESBL) development. A combined double disk synergy test (CDDST) was used to identify MBL-producing isolates. Results: 61 Proteus isolates, including P. Mirabilis 44/61 (77.04%), P. vulgaris 7/61 (11.47%), P. hauseri 5/61 (8.19%), and P. penneri 2/61 (3.27%) were collected. Most of the isolates were obtained from urine samples. P. hauseri isolates were more frequent in females. Resistance to tetracycline and nitrofurantoin antibiotics was observed in most Proteus isolates. P. penneri isolates were all resistant to antibiotics. ESBL production was observed in five ceftazidime-resistant isolates (p < 0.05). Conclusions: Cefepime and imipenem were found to have the lowest occurrence of antibiotic resistance among Proteus species, confirming that cefepime and imipenem can be used to treat Proteus infections. https://jidc.org/index.php/journal/article/view/17637Proteusextended-spectrum β-lactamasemultidrug resistanceantimicrobial resistance
spellingShingle Mahnaz Shafaei Fallah
Hadi Razavi Nikoo
Aylar Jamali
Alireza Mohebbi
Ezzat Allah Ghaemi
A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran
Journal of Infection in Developing Countries
Proteus
extended-spectrum β-lactamase
multidrug resistance
antimicrobial resistance
title A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran
title_full A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran
title_fullStr A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran
title_full_unstemmed A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran
title_short A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran
title_sort cross sectional study on the prevalence of multidrug resistant clinical isolates of proteus species in northern iran
topic Proteus
extended-spectrum β-lactamase
multidrug resistance
antimicrobial resistance
url https://jidc.org/index.php/journal/article/view/17637
work_keys_str_mv AT mahnazshafaeifallah acrosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran
AT hadirazavinikoo acrosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran
AT aylarjamali acrosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran
AT alirezamohebbi acrosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran
AT ezzatallahghaemi acrosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran
AT mahnazshafaeifallah crosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran
AT hadirazavinikoo crosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran
AT aylarjamali crosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran
AT alirezamohebbi crosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran
AT ezzatallahghaemi crosssectionalstudyontheprevalenceofmultidrugresistantclinicalisolatesofproteusspeciesinnortherniran